rs34774441
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004817.4(TJP2):c.2004G>A(p.Met668Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0592 in 1,614,088 control chromosomes in the GnomAD database, including 3,222 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_004817.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TJP2 | NM_004817.4 | c.2004G>A | p.Met668Ile | missense_variant | 14/23 | ENST00000377245.9 | NP_004808.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TJP2 | ENST00000377245.9 | c.2004G>A | p.Met668Ile | missense_variant | 14/23 | 1 | NM_004817.4 | ENSP00000366453.4 | ||
ENSG00000285130 | ENST00000642889.1 | c.2391G>A | p.Met797Ile | missense_variant | 16/25 | ENSP00000493780.1 |
Frequencies
GnomAD3 genomes AF: 0.0470 AC: 7156AN: 152176Hom.: 201 Cov.: 32
GnomAD3 exomes AF: 0.0539 AC: 13560AN: 251450Hom.: 483 AF XY: 0.0577 AC XY: 7842AN XY: 135898
GnomAD4 exome AF: 0.0605 AC: 88456AN: 1461794Hom.: 3021 Cov.: 32 AF XY: 0.0620 AC XY: 45090AN XY: 727224
GnomAD4 genome AF: 0.0470 AC: 7157AN: 152294Hom.: 201 Cov.: 32 AF XY: 0.0452 AC XY: 3368AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | Met645Ile in Exon 15 of TJP2: This variant is not expected to have clinical sign ificance because it has been identified in 6.5% (458/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs34774441). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 31, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at